LncRNA FOXD1-AS1 acts as a potential oncogenic biomarker in glioma.

CONCLUSIONS: These data indicated that FOXD1-AS1, a miR339/342 target, affected biological processes via protein eIF5a; thus, it might be considered as a new therapeutic target for glioblastoma.
PMID: 31102349 [PubMed - as supplied by publisher]

Source: CNS Neuroscience and Therapeutics - May 16, 2019 Category: Neuroscience Authors: Gao YF, Liu JY, Mao XY, He ZW, Zhu T, Wang ZB, Li X, Yin JY, Zhang W, Zhou HH, Liu ZQ Tags: CNS Neurosci Ther Source Type: research